Loading compound...
Small molecule inhibitor
Zotatifin is a small molecule drug currently being studied in clinical trials. It is being investigated for its potential use in treating various types of cancer, such as breast cancer, as well as for conditions like COVID-19.
How it worksZotatifin is a small molecule that targets specific biological processes within cells, though the exact way it works in the body is still being researched in clinical studies.
Used for
Breast cancer researchNeoplasm (cancer) researchCOVID-19 research
Conditions
Breast cancerNeoplasmsCOVID-19
Class
Small moleculeSmall molecule inhibitor
How to take
Zotatifin is currently in the investigational stage (clinical trials) and is not yet approved for general use by regulatory agencies for these conditions.
Talk to your doctor
Questions to ask
- ·What stage of clinical trials is Zotatifin in?
- ·How might Zotatifin affect my current cancer treatment?
- ·What are the potential risks of participating in a Zotatifin study?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
